HOUSTON, Aug. 24, 2020 /PRNewswire-PRWeb/ -- Houston's GEORGE R. BROWN Convention Center
announced they are deploying inventor and CEO Monzer Hourani's Integrated Viral Protection Air
Biodefence Filtration System™ at Avenida Houston.
"The time for action is now, and helping our hometown reopen in
record timing with this proven science that kills COVID-19 is so
important to me as we use Houston-based research to help lead us out of
this crisis and get us back to business," said Monzer Hourani, inventor, and founder of
Integrated Viral Protection's S1 model is an affordable, mobile,
plug-and-purify device proven to eliminate SARS-CoV-2 (99.999%),
anthrax spores (99.8%) and other airborne contaminants through a
heated filter without impacting the temperature of the ambient air.
A peer-reviewed study demonstrating how the heated air filtration
system has been proven to destroy SARS-CoV-2 and other airborne
pathogens on contact was published in Materials Physics Today.
For a video explaining IVP's novel family of mobile and
building-installed Catch and Kill™ air filtration and
purification solutions, please click here.
"The pandemic has created a number of challenges, but the
Houston First team is committed to finding opportunities for safe
and functional solutions that will lead the city and the
hospitality industry into recovery," said Michael Heckman, acting president and CEO of
Houston First Corporation. "Discovering new technology, new
possibilities and new partnerships will not only keep our community
safe but allow our economy to rebound."
ABOUT INTEGRATED VIRAL PROTECTION (IVP)
"We are excited to partner with Houston First and deploy this
one and only technology proven to eliminate airborne COVID-19
instantaneously. The invention by Monzer
Hourani and the breakthrough research conducted by the
Superconductivity Center of Texas
at The University of Houston, Galveston
National Laboratory at UTMB and Texas A&M Engineering and
Experiment Station is a public health game-changer and will offer a
sense of security to breathe with confidence indoors," said Dr.
Garrett Peel, principal at IVP.
The results are independently endorsed by premier researchers
including Professor Gang Chen at Massachusetts
Institute of Technology (MIT):
"Timely work with significant real world implications;" Professor
George Crabtree, Director of JCESR
at Argonne National Laboratory: "…will effectively serve as a mask
for indoor ventilation," and Professor Paul Chu Founding Director
at the Texas Center for Superconductivity at University of Houston (Father of Superconductivity,
Nobel Prize Nominee and National Medal of Science Awardee): "…as a
much needed single hope in this long depressing pandemic."
The research team is led by Dr. Zhifeng
Ren, Director, Texas Center for Superconductivity at
University of Houston and Dr. Luo Yu,
along with Dr. Faisal Cheema at
University of Houston College of
Medicine under the leadership of Dean Steve
Spann, Vice Chancellor and Vice President of Research and
Technology Transfer, Dr. Amr Elnashai and Chancellor and President
Renu Khator, Dr. Slobodan Paessler, Distinguished Chair of
Biodefense at Galveston National Laboratory and colleagues
including Dr. Johnny Peterson and
Dr. William Lawrence, Texas A&M University, Vice Chancellor of
Engineering and National Laboratories, Dr. Kathy Banks, Associate Dean for Research, The
Texas A&M Experiment Engineering Station, Dr. Joe Elabd and Director, NanoBio Systems
Laboratory, Dr. Arum Han and John
Sharp, Chancellor of the Texas A&M
The patent-pending BIODEFENSE INDOOR AIR PROTECTION
SYSTEM™ is FDA Compliant to Enforcement Policy for
Sterilizers, Disinfectant Devices and Air Purifiers During the
Coronavirus Disease - 2019 (COVID-19) Public Health Emergency | 21
CFR 880.5045 Medical Recirculation Air Cleaner and 21 CFR 880.6500
Medical UV Air Purifier | Class II Device) and permitted by the FDA
to be sold during the Coronavirus disease. For more information on
IVP, please visit IVPair.com.
SOURCE Integrated Viral Protection